Ismail SK, Norris L, O'Shea S, Higgins JR

2014

August

Thrombosis Research

Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.

Validated

WOS: 7 ()

134

2

234

239

Low molecular weight heparin (LMWH) prophylaxis has been recommended for morbidly obese pregnant women (>40kg/m(2)). There is very little data on the anticoagulant effects of LMWH in this group. We investigated two different dosing regimens; fixed dose and weight-adjusted dose on the anticoagulant effects of the LMWH tinzaparin used for thromboprophylaxis in obese pregnant women.

10.1016/j.thromres.2014.04.006